NICE warns over cost scrutiny in value-based pricing plans

NICE has backed the proposed value-based pricing scheme for medicines but warned that plans to reward innovation could waste NHS resources.

In a response to the recent DoH consultation, NICE chief executive Sir Andrew Dillon welcomed proposals for the NHS to pay prices for drugs that reflect therapeutic benefit.

But the institute warned that its role scrutinising effectiveness, and the legal right to access recommended treatments, must be retained to avoid worsening postcode lotteries in drug access in times of fiscal constraints.

NICE also said it was ‘very concerned’ about plans to vary thresholds for assessing the cost effectiveness of new drugs.

Under the plans, the DoH will determine cost effectiveness thresholds for new drugs based on burden of illness or unmet need. But NICE said decisions must strike a balance to ensure use of new products ‘does not deprive other patients of cost effective care’.

Rewarding innovative new drugs will lead to double counting of benefit, which will already have been captured in the cost effectiveness assessment, it added.

‘This will lead to poorer value for money and less efficient use of NHS resources compared with the current arrangements,’ it said.

Sir Andrew said: ‘We also share the government's ambition to ensure that the option exists for all new licensed drugs to be offered to those patients who can benefit from them, provided the price is a fair reflection of their value,’ he said.

NICE is set to play a prominent role as the primary advisory body under the plans, although the DoH said the details will depend on the outcome of the consultation.

It said it welcomes the opportunity to appraise drug benefits under the scheme if implemented. Sir Andrew said the aims of the plans could be achieved by adapting the existing NICE process.

‘We are confident that the government will want to take advantage of NICE's expertise and experience as it develops value-based pricing.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Redacting information from medical records - advice for GPs

Redacting information from medical records - advice for GPs

MDU medico-legal adviser Dr Ellie Mein provides advice for GPs on reacting information...

Medicine shortages set to continue despite Brexit delay

Medicine shortages set to continue despite Brexit delay

Medicine shortages are unlikely to improve as a result of Brexit being delayed healthcare...

Doctors less likely to be investigated for 'one-off' mistakes under new GMC rules

Doctors less likely to be investigated for 'one-off' mistakes under new GMC rules

The GMC is introducing new measures to reduce the number of full investigations in...

RCGP revokes Sultan of Brunei's honorary title over anti-LGBTQ laws

RCGP revokes Sultan of Brunei's honorary title over anti-LGBTQ laws

The RCGP has revoked the honorary title it awarded the Sultan of Brunei following...

Financial considerations for primary care networks

Financial considerations for primary care networks

Specialist accountant Laurence Slavin highlights the financial issues that practices...

Number of CCGs could be cut by 75% by April 2020

Number of CCGs could be cut by 75% by April 2020

Measures to cut the number of CCGs in England by more than three quarters could be...